• Featured Product
  • KD/KO Validated

SLC1A5/ASCT2 Polyklonaler Antikörper

SLC1A5/ASCT2 Polyklonal Antikörper für WB, IHC, IF/ICC, IF-P, IF-Fro, FC (Intra), Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, IF/ICC, IF-P, IF-Fro, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 20350-1-PBS

Synonyme

SLC1A5, AAAT, ASCT2, ATB(0), ATBO



Geprüfte Anwendungen

Produktinformation

20350-1-PBS bindet in WB, IHC, IF/ICC, IF-P, IF-Fro, FC (Intra), Indirect ELISA SLC1A5/ASCT2 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen SLC1A5/ASCT2 fusion protein Ag14182
Vollständiger Name solute carrier family 1 (neutral amino acid transporter), member 5
Berechnetes Molekulargewicht 541 aa, 57 kDa
Beobachtetes Molekulargewicht 55-70 kDa
GenBank-ZugangsnummerBC000062
Gene symbol SLC1A5/ASCT2
Gene ID (NCBI) 6510
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SLC1A5 (Solute Carrier Family 1, member 5), also named as ASCT2, a major glutamine transporter belonging to the SLC1 family and localized in the plasma membrane of several body districts. Consistent with the functions exerted by glutamine, SLC1A5 is involved in uptake of essential amino acids, activation of mTORC1 and glutamine-dependent tumor cell survival and growth. SLC1A5 is highly expressed in various malignancies and plays a critical role in the transformation, growth and survival of cancer cells (PMID: 30234109). High SLC1A5 expression is associated with poor prognosis in clear-cell renal cell carcinoma (PMID: 26599282).